Swiss National Bank Maravai Lifesciences Holdings, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Swiss National Bank holds 221,000 shares of MRVI stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221,000

Previous 221,000 -0.0%

Holding current value

$1.1 Million

Previous $1.58 Million 16.06%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$4.7 - $9.87 $119,850 - $251,684	-25,500 Reduced 10.34%	221,000 $1.45 Million
Q3 2023 Nov 08, 2023	BUY	$9.14 - $12.85 $23,764 - $33,410	2,600 Added 1.07%	246,500 $2.47 Million
Q2 2023 Aug 09, 2023	BUY	$12.09 - $15.0 $31,434 - $39,000	2,600 Added 1.08%	243,900 $3.03 Million
Q1 2023 May 10, 2023	SELL	$12.99 - $16.48 $372,813 - $472,976	-28,700 Reduced 10.63%	241,300 $3.38 Million
Q4 2022 Feb 08, 2023	BUY	$12.5 - $24.78 $61,250 - $121,422	4,900 Added 1.85%	270,000 $3.86 Million
Q3 2022 Nov 09, 2022	BUY	$20.6 - $30.37 $41,200 - $60,740	2,000 Added 0.76%	265,100 $6.77 Million
Q2 2022 Aug 09, 2022	SELL	$26.05 - $37.48 $28,655 - $41,228	-1,100 Reduced 0.42%	263,100 $7.48 Million
Q1 2022 May 09, 2022	BUY	$24.46 - $40.92 $450,064 - $752,928	18,400 Added 7.49%	264,200 $9.32 Million
Q4 2021 Feb 08, 2022	SELL	$35.0 - $45.94 $38,500 - $50,534	-1,100 Reduced 0.45%	245,800 $10.3 Million
Q3 2021 Nov 08, 2021	BUY	$36.8 - $60.62 $1.82 Million - $2.99 Million	49,400 Added 25.01%	246,900 $12.1 Million
Q2 2021 Aug 06, 2021	BUY	$32.46 - $45.0 $6.41 Million - $8.89 Million	197,500 New	197,500 $8.24 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $652M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Maravai Lifesciences Holdings, Inc. Transaction History